How about Changzhou Bairage Biopharmaceutical Co., Ltd.?

Introduction: Changzhou Bairage Biopharmaceutical Co., Ltd. is a Sino-foreign joint venture introduced by Jiangsu Province’s High-Level Innovation and Entrepreneurship Talent Plan and Changzhou City’s Leading Returned Talent Plan. It was established in April 2008 and registered in Changzhou Economic and Technological Development Zone, Jiangsu Province, has a registered capital of more than 22 million yuan, and the total investment in the first phase of the project exceeds 100 million yuan.

Bairage is a biopharmaceutical company that provides technologically advanced high-end biopharmaceutical products to the global market and has independent innovation capabilities. Its main business directions are biomedical materials, tissue engineering/regenerative medicine, and new drug delivery. R&D, production and sales of preparations, etc.

The founder of the company brought many years of experience in the United States and internationally leading technology back to China, and independently developed the BioRegen? biomedical technology platform, combined with a large number of NIH and NSF majors from many universities in the United States for more than ten years. The research results of the fund (totaling approximately US$15 million) have overcome unresolved technical and industrialization problems in the industry, made breakthrough progress, and achieved completely independent intellectual property rights. A number of high-end biomedical products developed by the BioRegen? technology platform have made important progress. Multiple R&D projects have filled domestic or international gaps, are at the international leading or advanced level, and have broken the technology monopoly of Western developed countries in related fields. This technological achievement has been protected by 5 domestic invention patents and more than 20 international invention patents. At the same time, the company has received funding from the Science and Technology Support Program (Industry) of the Jiangsu Provincial Department of Science and Technology and the National Small and Medium-sized Enterprise Innovation Fund.

Bairage built the first high-standard fully isolated clean production line in 2009 that fully complies with the requirements of China's SFDA, the European Union and the US FDA. In the same year, it obtained a Class II medical device production enterprise license. Class medical device production enterprise license. As of the end of 2011, the company has passed ISO 13485, ISO 9001, and domestic medical device GMP quality management system certification. One product has obtained the U.S. FDA registration certificate, three products have obtained the EU registration certificate, and one product has obtained the EU registration certificate. Obtain domestic Class II registration certificate.

Bairage established a sales center in Beijing in 2011. So far, the sales network covers more than 30 provinces and cities across the country. Our company has established long-term industry-university-research cooperation relationships with Shanghai Jiao Tong University and many other universities, and has established cooperative relationships with many well-known medical institutions at home and abroad, realizing the promotion and application of BioRegen? technology.

Changzhou Bairage Biopharmaceutical Co., Ltd. adheres to independent innovation and is committed to human health with first-class technology and scientific management. It is the company's mission to provide patients with better treatment options and improve their health. The company's goal is to become a new hope for the patients (New hopes for the patients), which is the company's unremitting pursuit.

Company contact information: 0519-88408555

No. 167, Dongfang East Road, Qishuyan District, Changzhou City

Legal representative: Shu Xiaozheng

Established Date: 2008-04-28

Registered capital: 31.659705 yuan

Region: Jiangsu Province

Unified social credit code: 91320412675465930M

Business status: In business

Industry: Manufacturing

Company type: Limited liability company (Taiwan, Hong Kong, Macao and domestic joint ventures)

English name: Changzhou Bioregen biopharmaceutical co., LTD.

Staff size: cooperation

Company address: Building B, No. 117, Xue Ye Road, Xinbei District, Changzhou City

Business scope: Production III Category 6864 medical and hygienic materials and dressings, sales of self-produced products; research and development, technology transfer and provision of related technical services for biomedicine, medical devices and related products; engaged in the production and sales of cosmetics (limited to the scope approved by the "Cosmetics Production License") , commission agency (except auction), import and export business.

(Except those involving special national management measures; projects that require approval according to law can only be carried out with approval from relevant departments)